$17.17 0.12 (+0.70%)
2/10/2012 4:00 PM

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Featured Broker Partners


Advertisement